Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.613779624207218.
The log-likelihood improved by 3.958.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.5659.
Step length converged once. Increasing MCMC sample size.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1497.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       3       16     1167      976      792      376      379      369 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     308      257      169       81       50       31       16        8 
degree16 degree18 
       1        1 
1 
disease_progression 
H-positive risk:  881 888 120 873 459 113 865 427 138 65 110 61 
H-negative risk:  888 881 865 873 427 459 113 120 110 138 61 65 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
60 new agents 
2 
disease_progression 
H-positive risk:  888 891 118 875 454 112 863 425 140 65 108 61 
H-negative risk:  891 888 863 875 425 454 112 118 108 140 61 65 
New BC onsets:  4
BC status:  4996 4 
BC subtype:  4996 4 

clinical_engagement 
diagnosis 
demography 
61 new agents 
3 
disease_progression 
H-positive risk:  898 896 120 876 446 114 865 416 138 66 105 60 
H-negative risk:  896 898 865 876 416 446 114 120 105 138 60 66 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
59 new agents 
4 
disease_progression 
H-positive risk:  901 894 120 877 447 115 867 412 138 64 104 61 
H-negative risk:  894 901 867 877 412 447 115 120 104 138 61 64 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 11 1 

clinical_engagement 
diagnosis 
demography 
58 new agents 
5 
disease_progression 
H-positive risk:  914 896 119 876 441 113 861 410 139 65 105 61 
H-negative risk:  896 914 861 876 410 441 113 119 105 139 61 65 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 12 2 

clinical_engagement 
diagnosis 
demography 
65 new agents 
6 
disease_progression 
H-positive risk:  920 908 120 869 437 115 854 409 140 65 105 58 
H-negative risk:  908 920 854 869 409 437 115 120 105 140 58 65 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 14 2 

clinical_engagement 
diagnosis 
demography 
63 new agents 
7 
disease_progression 
H-positive risk:  925 920 118 864 435 116 851 404 142 63 105 57 
H-negative risk:  920 925 851 864 404 435 116 118 105 142 57 63 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 16 4 

clinical_engagement 
diagnosis 
demography 
57 new agents 
8 
disease_progression 
H-positive risk:  931 919 120 861 435 122 850 394 144 62 106 56 
H-negative risk:  919 931 850 861 394 435 122 120 106 144 56 62 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 17 7 

clinical_engagement 
diagnosis 
demography 
63 new agents 
9 
disease_progression 
H-positive risk:  934 927 123 853 435 122 847 392 142 63 106 56 
H-negative risk:  927 934 847 853 392 435 122 123 106 142 56 63 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 18 7 

clinical_engagement 
diagnosis 
demography 
66 new agents 
10 
disease_progression 
H-positive risk:  940 929 120 855 433 124 841 393 142 65 104 54 
H-negative risk:  929 940 841 855 393 433 124 120 104 142 54 65 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 19 8 

clinical_engagement 
diagnosis 
demography 
48 new agents 
11 
disease_progression 
H-positive risk:  943 938 120 855 426 126 839 391 141 64 102 55 
H-negative risk:  938 943 839 855 391 426 126 120 102 141 55 64 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 21 8 

clinical_engagement 
diagnosis 
demography 
51 new agents 
12 
disease_progression 
H-positive risk:  948 943 120 847 420 124 839 390 145 64 103 57 
H-negative risk:  943 948 839 847 390 420 124 120 103 145 57 64 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 22 8 

clinical_engagement 
diagnosis 
demography 
51 new agents 
13 
disease_progression 
H-positive risk:  873 866 107 921 418 111 920 391 154 63 118 58 
H-negative risk:  866 873 920 921 391 418 111 107 118 154 58 63 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 20 8 

clinical_engagement 
diagnosis 
demography 
201 new agents 
14 
disease_progression 
H-positive risk:  896 899 107 866 428 112 872 435 152 61 116 56 
H-negative risk:  899 896 872 866 435 428 112 107 116 152 56 61 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 22 9 

clinical_engagement 
diagnosis 
demography 
65 new agents 
15 
disease_progression 
H-positive risk:  905 914 108 864 423 112 867 425 153 60 115 54 
H-negative risk:  914 905 867 864 425 423 112 108 115 153 54 60 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 25 7 

clinical_engagement 
diagnosis 
demography 
55 new agents 
16 
disease_progression 
H-positive risk:  908 915 110 865 415 111 872 421 154 59 116 54 
H-negative risk:  915 908 872 865 421 415 111 110 116 154 54 59 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 25 7 

clinical_engagement 
diagnosis 
demography 
50 new agents 
17 
disease_progression 
H-positive risk:  912 912 111 871 405 113 871 419 156 60 117 53 
H-negative risk:  912 912 871 871 419 405 113 111 117 156 53 60 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 26 11 

clinical_engagement 
diagnosis 
demography 
83 new agents 
18 
disease_progression 
H-positive risk:  905 919 111 876 404 110 873 415 160 58 116 53 
H-negative risk:  919 905 873 876 415 404 110 111 116 160 53 58 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 27 11 

clinical_engagement 
diagnosis 
demography 
68 new agents 
19 
disease_progression 
H-positive risk:  904 925 115 875 397 111 877 404 161 60 118 53 
H-negative risk:  925 904 877 875 404 397 111 115 118 161 53 60 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
54 new agents 
20 
disease_progression 
H-positive risk:  904 932 114 879 393 110 876 399 161 59 119 54 
H-negative risk:  932 904 876 879 399 393 110 114 119 161 54 59 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 29 11 

clinical_engagement 
diagnosis 
demography 
55 new agents 
21 
disease_progression 
H-positive risk:  902 928 115 891 392 113 883 390 160 58 117 51 
H-negative risk:  928 902 883 891 390 392 113 115 117 160 51 58 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 30 11 

clinical_engagement 
diagnosis 
demography 
49 new agents 
22 
disease_progression 
H-positive risk:  903 931 116 887 387 115 886 388 160 59 117 51 
H-negative risk:  931 903 886 887 388 387 115 116 117 160 51 59 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 32 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
23 
disease_progression 
H-positive risk:  909 939 119 886 384 116 884 382 155 60 115 51 
H-negative risk:  939 909 884 886 382 384 116 119 115 155 51 60 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 34 13 

clinical_engagement 
diagnosis 
demography 
59 new agents 
24 
disease_progression 
H-positive risk:  919 938 118 893 376 116 879 383 153 60 115 50 
H-negative risk:  938 919 879 893 383 376 116 118 115 153 50 60 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 33 14 

clinical_engagement 
diagnosis 
demography 
59 new agents 
25 
disease_progression 
H-positive risk:  848 879 108 960 376 106 951 375 163 57 130 47 
H-negative risk:  879 848 951 960 375 376 106 108 130 163 47 57 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 35 14 

clinical_engagement 
diagnosis 
demography 
183 new agents 
26 
disease_progression 
H-positive risk:  863 900 111 907 394 111 921 402 155 63 120 53 
H-negative risk:  900 863 921 907 402 394 111 111 120 155 53 63 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 36 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
27 
disease_progression 
H-positive risk:  865 901 111 905 397 111 916 401 157 60 123 53 
H-negative risk:  901 865 916 905 401 397 111 111 123 157 53 60 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 38 14 

clinical_engagement 
diagnosis 
demography 
55 new agents 
28 
disease_progression 
H-positive risk:  860 903 109 909 390 111 917 407 157 60 124 53 
H-negative risk:  903 860 917 909 407 390 111 109 124 157 53 60 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 39 14 

clinical_engagement 
diagnosis 
demography 
52 new agents 
29 
disease_progression 
H-positive risk:  870 902 109 900 395 112 916 402 156 61 123 54 
H-negative risk:  902 870 916 900 402 395 112 109 123 156 54 61 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 40 14 

clinical_engagement 
diagnosis 
demography 
60 new agents 
30 
disease_progression 
H-positive risk:  869 904 109 904 389 114 922 395 156 60 124 54 
H-negative risk:  904 869 922 904 395 389 114 109 124 156 54 60 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 42 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
31 
disease_progression 
H-positive risk:  864 916 110 897 385 116 918 399 153 59 128 55 
H-negative risk:  916 864 918 897 399 385 116 110 128 153 55 59 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 41 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
32 
disease_progression 
H-positive risk:  875 916 109 896 383 119 914 393 155 57 128 55 
H-negative risk:  916 875 914 896 393 383 119 109 128 155 55 57 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 42 14 

clinical_engagement 
diagnosis 
demography 
56 new agents 
33 
disease_progression 
H-positive risk:  874 918 108 897 381 118 919 389 156 57 129 54 
H-negative risk:  918 874 919 897 389 381 118 108 129 156 54 57 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 44 14 

clinical_engagement 
diagnosis 
demography 
54 new agents 
34 
disease_progression 
H-positive risk:  876 925 111 894 381 117 914 389 154 56 129 54 
H-negative risk:  925 876 914 894 389 381 117 111 129 154 54 56 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 43 14 

clinical_engagement 
diagnosis 
demography 
53 new agents 
35 
disease_progression 
H-positive risk:  881 927 110 898 381 116 911 383 152 56 130 55 
H-negative risk:  927 881 911 898 383 381 116 110 130 152 55 56 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 44 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
36 
disease_progression 
H-positive risk:  875 933 110 898 383 118 904 386 155 53 132 53 
H-negative risk:  933 875 904 898 386 383 118 110 132 155 53 53 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 44 18 

clinical_engagement 
diagnosis 
demography 
48 new agents 
37 
disease_progression 
H-positive risk:  798 861 104 975 383 113 973 386 161 53 141 52 
H-negative risk:  861 798 973 975 386 383 113 104 141 161 52 53 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 45 18 

clinical_engagement 
diagnosis 
demography 
150 new agents 
38 
disease_progression 
H-positive risk:  809 878 107 944 399 112 952 399 157 56 143 44 
H-negative risk:  878 809 952 944 399 399 112 107 143 157 44 56 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 47 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
39 
disease_progression 
H-positive risk:  816 877 108 938 406 113 945 393 158 57 144 45 
H-negative risk:  877 816 945 938 393 406 113 108 144 158 45 57 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 48 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
40 
disease_progression 
H-positive risk:  824 884 109 933 399 113 948 388 156 56 145 45 
H-negative risk:  884 824 948 933 388 399 113 109 145 156 45 56 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 49 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
41 
disease_progression 
H-positive risk:  820 891 110 930 398 112 956 384 151 56 146 46 
H-negative risk:  891 820 956 930 384 398 112 110 146 151 46 56 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 49 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
42 
disease_progression 
H-positive risk:  830 892 113 933 394 114 950 378 149 53 147 47 
H-negative risk:  892 830 950 933 378 394 114 113 147 149 47 53 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 50 18 

clinical_engagement 
diagnosis 
demography 
55 new agents 
43 
disease_progression 
H-positive risk:  827 887 112 938 389 116 950 382 151 53 150 45 
H-negative risk:  887 827 950 938 382 389 116 112 150 151 45 53 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
44 
disease_progression 
H-positive risk:  836 890 113 944 385 115 948 369 154 52 149 45 
H-negative risk:  890 836 948 944 369 385 115 113 149 154 45 52 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
45 
disease_progression 
H-positive risk:  836 894 112 944 380 115 949 372 151 52 148 47 
H-negative risk:  894 836 949 944 372 380 115 112 148 151 47 52 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 56 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
46 
disease_progression 
H-positive risk:  841 890 109 944 375 117 948 375 153 51 149 48 
H-negative risk:  890 841 948 944 375 375 117 109 149 153 48 51 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 53 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
47 
disease_progression 
H-positive risk:  849 894 107 938 372 117 952 372 151 52 149 47 
H-negative risk:  894 849 952 938 372 372 117 107 149 151 47 52 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 55 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
48 
disease_progression 
H-positive risk:  850 892 108 939 364 116 956 372 152 53 152 46 
H-negative risk:  892 850 956 939 372 364 116 108 152 152 46 53 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 56 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
49 
disease_progression 
H-positive risk:  804 830 104 1005 356 113 1015 365 156 52 154 46 
H-negative risk:  830 804 1015 1005 365 356 113 104 154 156 46 52 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 59 19 

clinical_engagement 
diagnosis 
demography 
139 new agents 
50 
disease_progression 
H-positive risk:  821 846 106 980 364 115 986 377 151 56 148 50 
H-negative risk:  846 821 986 980 377 364 115 106 148 151 50 56 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 55 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
51 
disease_progression 
H-positive risk:  819 842 105 980 374 116 976 387 144 59 149 49 
H-negative risk:  842 819 976 980 387 374 116 105 149 144 49 59 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
59 new agents 
52 
disease_progression 
H-positive risk:  822 838 107 983 373 117 976 385 142 59 148 50 
H-negative risk:  838 822 976 983 385 373 117 107 148 142 50 59 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 56 18 

clinical_engagement 
diagnosis 
demography 
58 new agents 
53 
disease_progression 
H-positive risk:  829 838 108 982 371 117 968 386 142 59 149 51 
H-negative risk:  838 829 968 982 386 371 117 108 149 142 51 59 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 54 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
54 
disease_progression 
H-positive risk:  828 837 105 982 375 116 962 388 145 59 151 52 
H-negative risk:  837 828 962 982 388 375 116 105 151 145 52 59 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 56 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
55 
disease_progression 
H-positive risk:  838 840 105 986 375 115 954 379 146 59 153 50 
H-negative risk:  840 838 954 986 379 375 115 105 153 146 50 59 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 57 18 

clinical_engagement 
diagnosis 
demography 
86 new agents 
56 
disease_progression 
H-positive risk:  845 838 107 981 373 117 962 376 140 56 154 51 
H-negative risk:  838 845 962 981 376 373 117 107 154 140 51 56 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
57 
disease_progression 
H-positive risk:  846 848 109 975 371 117 963 375 138 57 151 50 
H-negative risk:  848 846 963 975 375 371 117 109 151 138 50 57 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 63 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
58 
disease_progression 
H-positive risk:  851 853 107 970 375 114 960 375 138 55 151 51 
H-negative risk:  853 851 960 970 375 375 114 107 151 138 51 55 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 62 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
59 
disease_progression 
H-positive risk:  856 859 107 973 376 113 962 364 136 54 151 49 
H-negative risk:  859 856 962 973 364 376 113 107 151 136 49 54 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 65 15 

clinical_engagement 
diagnosis 
demography 
58 new agents 
60 
disease_progression 
H-positive risk:  860 869 109 972 369 114 954 364 136 54 151 48 
H-negative risk:  869 860 954 972 364 369 114 109 151 136 48 54 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 65 16 

clinical_engagement 
diagnosis 
demography 
57 new agents 
61 
disease_progression 
H-positive risk:  814 811 104 1030 369 106 1002 366 143 55 154 46 
H-negative risk:  811 814 1002 1030 366 369 106 104 154 143 46 55 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 68 16 

clinical_engagement 
diagnosis 
demography 
130 new agents 
62 
disease_progression 
H-positive risk:  812 810 106 1012 389 107 979 385 139 59 149 53 
H-negative risk:  810 812 979 1012 385 389 107 106 149 139 53 59 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
63 
disease_progression 
H-positive risk:  820 819 105 1010 385 105 979 385 135 57 148 52 
H-negative risk:  819 820 979 1010 385 385 105 105 148 135 52 57 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
64 
disease_progression 
H-positive risk:  826 820 104 1009 384 105 981 385 134 56 148 48 
H-negative risk:  820 826 981 1009 385 384 105 104 148 134 48 56 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
56 new agents 
65 
disease_progression 
H-positive risk:  825 822 106 1013 381 107 978 382 133 55 150 48 
H-negative risk:  822 825 978 1013 382 381 107 106 150 133 48 55 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
66 
disease_progression 
H-positive risk:  827 825 108 1006 383 105 974 388 136 54 149 45 
H-negative risk:  825 827 974 1006 388 383 105 108 149 136 45 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 69 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
67 
disease_progression 
H-positive risk:  832 823 107 1016 378 107 969 387 132 53 152 44 
H-negative risk:  823 832 969 1016 387 378 107 107 152 132 44 53 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
68 
disease_progression 
H-positive risk:  836 818 107 1030 369 107 960 391 133 53 151 45 
H-negative risk:  818 836 960 1030 391 369 107 107 151 133 45 53 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
69 
disease_progression 
H-positive risk:  832 826 109 1030 372 107 949 390 133 54 152 46 
H-negative risk:  826 832 949 1030 390 372 107 109 152 133 46 54 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
53 new agents 
70 
disease_progression 
H-positive risk:  834 828 108 1027 365 108 944 398 133 56 154 45 
H-negative risk:  828 834 944 1027 398 365 108 108 154 133 45 56 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
71 
disease_progression 
H-positive risk:  835 822 110 1027 361 106 956 389 133 59 156 46 
H-negative risk:  822 835 956 1027 389 361 106 110 156 133 46 59 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
63 new agents 
72 
disease_progression 
H-positive risk:  833 825 110 1034 362 108 951 389 132 56 154 46 
H-negative risk:  825 833 951 1034 389 362 108 110 154 132 46 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
73 
disease_progression 
H-positive risk:  787 766 104 1098 361 103 993 391 139 54 159 45 
H-negative risk:  766 787 993 1098 391 361 103 104 159 139 45 54 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 75 16 

clinical_engagement 
diagnosis 
demography 
117 new agents 
74 
disease_progression 
H-positive risk:  792 772 104 1086 369 101 969 411 138 57 156 45 
H-negative risk:  772 792 969 1086 411 369 101 104 156 138 45 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 75 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
75 
disease_progression 
H-positive risk:  799 775 104 1072 378 102 966 404 140 57 153 50 
H-negative risk:  775 799 966 1072 404 378 102 104 153 140 50 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
76 
disease_progression 
H-positive risk:  799 777 105 1069 373 103 974 396 143 57 154 50 
H-negative risk:  777 799 974 1069 396 373 103 105 154 143 50 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 74 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
77 
disease_progression 
H-positive risk:  801 788 106 1061 368 105 969 400 145 56 151 50 
H-negative risk:  788 801 969 1061 400 368 105 106 151 145 50 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
78 
disease_progression 
H-positive risk:  798 785 107 1065 364 105 974 399 144 58 150 51 
H-negative risk:  785 798 974 1065 399 364 105 107 150 144 51 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
79 
disease_progression 
H-positive risk:  796 790 103 1068 360 103 977 397 146 58 150 52 
H-negative risk:  790 796 977 1068 397 360 103 103 150 146 52 58 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
80 
disease_progression 
H-positive risk:  793 795 102 1057 368 102 982 394 148 59 147 53 
H-negative risk:  795 793 982 1057 394 368 102 102 147 148 53 59 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
81 
disease_progression 
H-positive risk:  790 794 102 1066 362 103 984 392 152 56 145 54 
H-negative risk:  794 790 984 1066 392 362 103 102 145 152 54 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
82 
disease_progression 
H-positive risk:  780 791 105 1065 363 103 986 402 156 52 142 55 
H-negative risk:  791 780 986 1065 402 363 103 105 142 156 55 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
83 
disease_progression 
H-positive risk:  780 792 107 1064 354 107 992 400 154 54 139 57 
H-negative risk:  792 780 992 1064 400 354 107 107 139 154 57 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
84 
disease_progression 
H-positive risk:  777 797 106 1064 355 109 997 390 156 54 139 56 
H-negative risk:  797 777 997 1064 390 355 109 106 139 156 56 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
85 
disease_progression 
H-positive risk:  730 755 100 1111 351 100 1046 389 160 55 148 55 
H-negative risk:  755 730 1046 1111 389 351 100 100 148 160 55 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
108 new agents 
86 
disease_progression 
H-positive risk:  747 745 100 1112 356 97 1031 394 152 63 152 51 
H-negative risk:  745 747 1031 1112 394 356 97 100 152 152 51 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
87 
disease_progression 
H-positive risk:  750 751 101 1108 361 95 1023 391 157 58 152 53 
H-negative risk:  751 750 1023 1108 391 361 95 101 152 157 53 58 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
88 
disease_progression 
H-positive risk:  757 758 98 1106 359 95 1020 386 157 57 152 55 
H-negative risk:  758 757 1020 1106 386 359 95 98 152 157 55 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
89 
disease_progression 
H-positive risk:  758 761 95 1100 354 97 1016 393 156 58 157 55 
H-negative risk:  761 758 1016 1100 393 354 97 95 157 156 55 58 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
90 
disease_progression 
H-positive risk:  755 762 99 1104 348 100 1020 393 153 55 158 53 
H-negative risk:  762 755 1020 1104 393 348 100 99 158 153 53 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
91 
disease_progression 
H-positive risk:  761 758 99 1106 346 100 1028 388 151 56 157 50 
H-negative risk:  758 761 1028 1106 388 346 100 99 157 151 50 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
92 
disease_progression 
H-positive risk:  765 759 101 1106 349 99 1025 382 150 54 158 52 
H-negative risk:  759 765 1025 1106 382 349 99 101 158 150 52 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
93 
disease_progression 
H-positive risk:  765 765 99 1111 347 98 1013 380 154 52 160 56 
H-negative risk:  765 765 1013 1111 380 347 98 99 160 154 56 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
94 
disease_progression 
H-positive risk:  768 763 101 1110 344 97 1008 377 158 54 163 57 
H-negative risk:  763 768 1008 1110 377 344 97 101 163 158 57 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
95 
disease_progression 
H-positive risk:  776 764 101 1106 344 97 1004 372 158 57 164 57 
H-negative risk:  764 776 1004 1106 372 344 97 101 164 158 57 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
96 
disease_progression 
H-positive risk:  770 756 102 1105 349 100 1012 371 155 60 164 56 
H-negative risk:  756 770 1012 1105 371 349 100 102 164 155 56 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
97 
disease_progression 
H-positive risk:  725 698 88 1160 357 101 1059 361 157 59 179 56 
H-negative risk:  698 725 1059 1160 361 357 101 88 179 157 56 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
111 new agents 
98 
disease_progression 
H-positive risk:  712 695 90 1141 377 99 1070 367 155 57 176 61 
H-negative risk:  695 712 1070 1141 367 377 99 90 176 155 61 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
99 
disease_progression 
H-positive risk:  711 693 90 1142 378 100 1075 364 154 56 175 62 
H-negative risk:  693 711 1075 1142 364 378 100 90 175 154 62 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
100 
disease_progression 
H-positive risk:  708 705 90 1136 376 98 1084 362 153 54 174 60 
H-negative risk:  705 708 1084 1136 362 376 98 90 174 153 60 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
101 
disease_progression 
H-positive risk:  711 709 91 1130 368 97 1081 373 151 52 176 61 
H-negative risk:  709 711 1081 1130 373 368 97 91 176 151 61 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
102 
disease_progression 
H-positive risk:  715 708 92 1123 366 96 1090 372 152 51 177 58 
H-negative risk:  708 715 1090 1123 372 366 96 92 177 152 58 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
103 
disease_progression 
H-positive risk:  714 697 93 1136 367 99 1092 369 151 50 175 57 
H-negative risk:  697 714 1092 1136 369 367 99 93 175 151 57 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
51 new agents 
104 
disease_progression 
H-positive risk:  717 704 91 1127 370 99 1100 361 150 51 174 56 
H-negative risk:  704 717 1100 1127 361 370 99 91 174 150 56 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
105 
disease_progression 
H-positive risk:  720 709 91 1119 373 100 1100 356 152 50 174 56 
H-negative risk:  709 720 1100 1119 356 373 100 91 174 152 56 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
106 
disease_progression 
H-positive risk:  727 708 93 1114 369 99 1104 356 150 51 173 56 
H-negative risk:  708 727 1104 1114 356 369 99 93 173 150 56 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
107 
disease_progression 
H-positive risk:  726 710 95 1121 369 100 1102 355 151 47 171 53 
H-negative risk:  710 726 1102 1121 355 369 100 95 171 151 53 47 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
108 
disease_progression 
H-positive risk:  726 713 97 1120 365 101 1103 353 150 47 171 54 
H-negative risk:  713 726 1103 1120 353 365 101 97 171 150 54 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
109 
disease_progression 
H-positive risk:  682 673 90 1156 362 97 1145 362 155 49 176 53 
H-negative risk:  673 682 1145 1156 362 362 97 90 176 155 53 49 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
110 
disease_progression 
H-positive risk:  678 667 90 1143 379 97 1139 374 150 52 176 55 
H-negative risk:  667 678 1139 1143 374 379 97 90 176 150 55 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
88 new agents 
111 
disease_progression 
H-positive risk:  678 674 90 1133 380 98 1144 365 154 55 173 56 
H-negative risk:  674 678 1144 1133 365 380 98 90 173 154 56 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
112 
disease_progression 
H-positive risk:  679 672 88 1131 379 98 1145 369 154 56 170 59 
H-negative risk:  672 679 1145 1131 369 379 98 88 170 154 59 56 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 77 13 

clinical_engagement 
diagnosis 
demography 
72 new agents 
113 
disease_progression 
H-positive risk:  677 677 86 1140 377 100 1150 362 154 51 170 56 
H-negative risk:  677 677 1150 1140 362 377 100 86 170 154 56 51 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 77 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
114 
disease_progression 
H-positive risk:  682 667 86 1149 375 98 1148 362 152 53 170 58 
H-negative risk:  667 682 1148 1149 362 375 98 86 170 152 58 53 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 78 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
115 
disease_progression 
H-positive risk:  686 667 87 1143 377 98 1152 358 151 51 169 61 
H-negative risk:  667 686 1152 1143 358 377 98 87 169 151 61 51 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 79 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
116 
disease_progression 
H-positive risk:  691 670 85 1145 378 98 1136 365 151 52 166 63 
H-negative risk:  670 691 1136 1145 365 378 98 85 166 151 63 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 82 14 

clinical_engagement 
diagnosis 
demography 
74 new agents 
117 
disease_progression 
H-positive risk:  690 667 87 1149 377 100 1136 373 147 52 162 60 
H-negative risk:  667 690 1136 1149 373 377 100 87 162 147 60 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 85 15 

clinical_engagement 
diagnosis 
demography 
83 new agents 
118 
disease_progression 
H-positive risk:  693 677 85 1139 379 103 1130 376 145 55 162 56 
H-negative risk:  677 693 1130 1139 376 379 103 85 162 145 56 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 85 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
119 
disease_progression 
H-positive risk:  692 678 85 1134 379 106 1134 373 147 53 161 58 
H-negative risk:  678 692 1134 1134 373 379 106 85 161 147 58 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 86 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
120 
disease_progression 
H-positive risk:  686 681 82 1129 388 106 1141 371 146 51 162 57 
H-negative risk:  681 686 1141 1129 371 388 106 82 162 146 57 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
88 new agents 
121 
disease_progression 
H-positive risk:  650 643 78 1179 385 91 1172 370 164 47 161 60 
H-negative risk:  643 650 1172 1179 370 385 91 78 161 164 60 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 86 15 

clinical_engagement 
diagnosis 
demography 
97 new agents 
122 
disease_progression 
H-positive risk:  653 645 76 1168 399 89 1159 380 165 49 154 63 
H-negative risk:  645 653 1159 1168 380 399 89 76 154 165 63 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
123 
disease_progression 
H-positive risk:  650 648 77 1176 390 88 1164 381 163 48 150 65 
H-negative risk:  648 650 1164 1176 381 390 88 77 150 163 65 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
124 
disease_progression 
H-positive risk:  652 650 77 1172 391 89 1163 376 163 52 147 68 
H-negative risk:  650 652 1163 1172 376 391 89 77 147 163 68 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
125 
disease_progression 
H-positive risk:  649 650 76 1172 391 88 1170 372 164 53 148 67 
H-negative risk:  650 649 1170 1172 372 391 88 76 148 164 67 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
126 
disease_progression 
H-positive risk:  645 647 77 1170 393 89 1173 374 165 55 147 65 
H-negative risk:  647 645 1173 1170 374 393 89 77 147 165 65 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
127 
disease_progression 
H-positive risk:  642 652 76 1164 387 88 1184 373 167 56 146 65 
H-negative risk:  652 642 1184 1164 373 387 88 76 146 167 65 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
62 new agents 
128 
disease_progression 
H-positive risk:  644 648 76 1166 387 88 1188 371 166 56 146 64 
H-negative risk:  648 644 1188 1166 371 387 88 76 146 166 64 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 94 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
129 
disease_progression 
H-positive risk:  644 646 80 1166 384 88 1189 370 170 52 148 63 
H-negative risk:  646 644 1189 1166 370 384 88 80 148 170 63 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
130 
disease_progression 
H-positive risk:  636 652 79 1164 383 87 1192 380 169 50 146 62 
H-negative risk:  652 636 1192 1164 380 383 87 79 146 169 62 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
131 
disease_progression 
H-positive risk:  643 653 79 1163 381 86 1189 380 167 48 148 63 
H-negative risk:  653 643 1189 1163 380 381 86 79 148 167 63 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
132 
disease_progression 
H-positive risk:  640 657 80 1150 379 88 1190 382 171 49 150 64 
H-negative risk:  657 640 1190 1150 382 379 88 80 150 171 64 49 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
133 
disease_progression 
H-positive risk:  643 655 81 1147 375 90 1198 377 171 49 149 65 
H-negative risk:  655 643 1198 1147 377 375 90 81 149 171 65 49 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
134 
disease_progression 
H-positive risk:  649 649 82 1156 379 88 1184 381 166 53 145 68 
H-negative risk:  649 649 1184 1156 381 379 88 82 145 166 68 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
135 
disease_progression 
H-positive risk:  649 643 83 1167 375 90 1193 370 166 52 144 68 
H-negative risk:  643 649 1193 1167 370 375 90 83 144 166 68 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
136 
disease_progression 
H-positive risk:  650 644 84 1171 378 89 1189 369 162 53 142 69 
H-negative risk:  644 650 1189 1171 369 378 89 84 142 162 69 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
137 
disease_progression 
H-positive risk:  654 637 85 1172 383 89 1195 360 162 53 142 68 
H-negative risk:  637 654 1195 1172 360 383 89 85 142 162 68 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
138 
disease_progression 
H-positive risk:  664 637 84 1169 385 91 1195 354 160 54 141 66 
H-negative risk:  637 664 1195 1169 354 385 91 84 141 160 66 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
56 new agents 
139 
disease_progression 
H-positive risk:  656 636 85 1171 383 92 1202 360 157 52 142 64 
H-negative risk:  636 656 1202 1171 360 383 92 85 142 157 64 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
140 
disease_progression 
H-positive risk:  656 633 84 1179 370 92 1209 365 154 53 140 65 
H-negative risk:  633 656 1209 1179 365 370 92 84 140 154 65 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
141 
disease_progression 
H-positive risk:  658 631 84 1177 367 91 1207 371 158 52 138 66 
H-negative risk:  631 658 1207 1177 371 367 91 84 138 158 66 52 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
142 
disease_progression 
H-positive risk:  665 637 82 1172 375 90 1200 366 155 52 141 65 
H-negative risk:  637 665 1200 1172 366 375 90 82 141 155 65 52 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
143 
disease_progression 
H-positive risk:  667 636 79 1179 374 88 1208 356 155 52 142 64 
H-negative risk:  636 667 1208 1179 356 374 88 79 142 155 64 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
144 
disease_progression 
H-positive risk:  666 641 79 1177 378 89 1204 355 157 52 140 62 
H-negative risk:  641 666 1204 1177 355 378 89 79 140 157 62 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
145 
disease_progression 
H-positive risk:  656 640 81 1166 386 87 1209 365 161 49 139 61 
H-negative risk:  640 656 1209 1166 365 386 87 81 139 161 61 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
146 
disease_progression 
H-positive risk:  658 644 80 1152 394 87 1206 373 154 54 140 58 
H-negative risk:  644 658 1206 1152 373 394 87 80 140 154 58 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
147 
disease_progression 
H-positive risk:  663 651 78 1147 390 88 1195 382 154 50 141 61 
H-negative risk:  651 663 1195 1147 382 390 88 78 141 154 61 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
148 
disease_progression 
H-positive risk:  670 652 77 1147 386 87 1195 380 154 50 142 60 
H-negative risk:  652 670 1195 1147 380 386 87 77 142 154 60 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
149 
disease_progression 
H-positive risk:  669 652 78 1143 384 87 1194 387 155 49 144 58 
H-negative risk:  652 669 1194 1143 387 384 87 78 144 155 58 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
54 new agents 
150 
disease_progression 
H-positive risk:  660 657 77 1145 384 88 1191 393 155 50 143 57 
H-negative risk:  657 660 1191 1145 393 384 88 77 143 155 57 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
151 
disease_progression 
H-positive risk:  667 656 80 1139 388 87 1192 389 154 49 144 55 
H-negative risk:  656 667 1192 1139 389 388 87 80 144 154 55 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
152 
disease_progression 
H-positive risk:  667 661 81 1148 383 87 1193 383 153 48 141 55 
H-negative risk:  661 667 1193 1148 383 383 87 81 141 153 55 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
153 
disease_progression 
H-positive risk:  672 662 81 1147 388 87 1189 377 153 50 138 56 
H-negative risk:  662 672 1189 1147 377 388 87 81 138 153 56 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
154 
disease_progression 
H-positive risk:  659 664 82 1145 385 91 1192 384 151 53 138 56 
H-negative risk:  664 659 1192 1145 384 385 91 82 138 151 56 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
91 new agents 
155 
disease_progression 
H-positive risk:  658 671 82 1140 378 92 1198 384 150 52 139 56 
H-negative risk:  671 658 1198 1140 384 378 92 82 139 150 56 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
156 
disease_progression 
H-positive risk:  664 671 83 1146 374 92 1192 377 150 53 141 57 
H-negative risk:  671 664 1192 1146 377 374 92 83 141 150 57 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
157 
disease_progression 
H-positive risk:  658 676 81 1149 373 90 1189 379 148 54 142 61 
H-negative risk:  676 658 1189 1149 379 373 90 81 142 148 61 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
158 
disease_progression 
H-positive risk:  653 680 80 1135 382 89 1177 401 146 53 141 63 
H-negative risk:  680 653 1177 1135 401 382 89 80 141 146 63 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
159 
disease_progression 
H-positive risk:  658 673 81 1131 388 92 1168 408 144 51 142 64 
H-negative risk:  673 658 1168 1131 408 388 92 81 142 144 64 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
160 
disease_progression 
H-positive risk:  652 663 84 1133 388 93 1181 409 143 52 142 60 
H-negative risk:  663 652 1181 1133 409 388 93 84 142 143 60 52 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
161 
disease_progression 
H-positive risk:  652 664 83 1129 392 93 1177 413 145 52 139 61 
H-negative risk:  664 652 1177 1129 413 392 93 83 139 145 61 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
162 
disease_progression 
H-positive risk:  659 661 85 1127 396 90 1179 408 142 53 139 61 
H-negative risk:  661 659 1179 1127 408 396 90 85 139 142 61 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
163 
disease_progression 
H-positive risk:  664 668 85 1132 383 90 1186 404 142 51 137 58 
H-negative risk:  668 664 1186 1132 404 383 90 85 137 142 58 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
164 
disease_progression 
H-positive risk:  668 669 83 1136 386 92 1181 399 140 50 139 57 
H-negative risk:  669 668 1181 1136 399 386 92 83 139 140 57 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
165 
disease_progression 
H-positive risk:  674 665 79 1141 381 94 1174 404 140 51 139 58 
H-negative risk:  665 674 1174 1141 404 381 94 79 139 140 58 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
166 
disease_progression 
H-positive risk:  675 658 79 1137 386 93 1180 402 139 50 144 57 
H-negative risk:  658 675 1180 1137 402 386 93 79 144 139 57 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
167 
disease_progression 
H-positive risk:  675 652 81 1140 381 94 1184 397 142 50 146 58 
H-negative risk:  652 675 1184 1140 397 381 94 81 146 142 58 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
168 
disease_progression 
H-positive risk:  677 649 82 1144 383 94 1180 397 139 49 150 56 
H-negative risk:  649 677 1180 1144 397 383 94 82 150 139 56 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
169 
disease_progression 
H-positive risk:  683 650 82 1137 378 94 1178 402 136 51 150 59 
H-negative risk:  650 683 1178 1137 402 378 94 82 150 136 59 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
170 
disease_progression 
H-positive risk:  675 651 81 1138 382 95 1169 412 139 51 147 60 
H-negative risk:  651 675 1169 1138 412 382 95 81 147 139 60 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
171 
disease_progression 
H-positive risk:  674 655 84 1141 383 95 1159 413 137 52 146 61 
H-negative risk:  655 674 1159 1141 413 383 95 84 146 137 61 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
84 new agents 
172 
disease_progression 
H-positive risk:  665 654 84 1134 395 93 1163 420 136 53 143 60 
H-negative risk:  654 665 1163 1134 420 395 93 84 143 136 60 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
51 new agents 
173 
disease_progression 
H-positive risk:  658 653 83 1128 402 94 1162 424 137 55 143 61 
H-negative risk:  653 658 1162 1128 424 402 94 83 143 137 61 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
174 
disease_progression 
H-positive risk:  649 658 84 1125 412 90 1167 417 138 55 144 61 
H-negative risk:  658 649 1167 1125 417 412 90 84 144 138 61 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
175 
disease_progression 
H-positive risk:  645 656 83 1118 417 92 1163 421 143 58 143 61 
H-negative risk:  656 645 1163 1118 421 417 92 83 143 143 61 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
176 
disease_progression 
H-positive risk:  643 650 82 1126 412 94 1161 424 142 59 145 62 
H-negative risk:  650 643 1161 1126 424 412 94 82 145 142 62 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
177 
disease_progression 
H-positive risk:  647 654 81 1125 415 95 1155 425 141 59 142 61 
H-negative risk:  654 647 1155 1125 425 415 95 81 142 141 61 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
178 
disease_progression 
H-positive risk:  648 659 81 1128 414 97 1154 417 139 58 143 62 
H-negative risk:  659 648 1154 1128 417 414 97 81 143 139 62 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
179 
disease_progression 
H-positive risk:  651 660 79 1128 412 99 1162 413 140 58 142 56 
H-negative risk:  660 651 1162 1128 413 412 99 79 142 140 56 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
180 
disease_progression 
H-positive risk:  660 654 79 1126 418 100 1151 417 140 57 140 58 
H-negative risk:  654 660 1151 1126 417 418 100 79 140 140 58 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
181 
disease_progression 
H-positive risk:  660 658 78 1122 428 101 1146 415 143 56 137 56 
H-negative risk:  658 660 1146 1122 415 428 101 78 137 143 56 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
182 
disease_progression 
H-positive risk:  664 653 81 1119 430 98 1138 417 144 60 136 60 
H-negative risk:  653 664 1138 1119 417 430 98 81 136 144 60 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
183 
disease_progression 
H-positive risk:  664 653 76 1119 440 98 1135 415 144 59 137 60 
H-negative risk:  653 664 1135 1119 415 440 98 76 137 144 60 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
184 
disease_progression 
H-positive risk:  661 645 76 1128 443 98 1147 408 145 54 135 60 
H-negative risk:  645 661 1147 1128 408 443 98 76 135 145 60 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
185 
disease_progression 
H-positive risk:  664 641 76 1123 443 98 1149 414 145 52 134 61 
H-negative risk:  641 664 1149 1123 414 443 98 76 134 145 61 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
186 
disease_progression 
H-positive risk:  659 647 76 1118 440 98 1150 413 144 54 138 63 
H-negative risk:  647 659 1150 1118 413 440 98 76 138 144 63 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
187 
disease_progression 
H-positive risk:  663 645 76 1121 444 94 1144 411 145 56 138 63 
H-negative risk:  645 663 1144 1121 411 444 94 76 138 145 63 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
188 
disease_progression 
H-positive risk:  661 645 75 1110 445 93 1148 413 148 56 144 62 
H-negative risk:  645 661 1148 1110 413 445 93 75 144 148 62 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
189 
disease_progression 
H-positive risk:  661 641 77 1110 443 96 1148 412 150 56 145 61 
H-negative risk:  641 661 1148 1110 412 443 96 77 145 150 61 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
190 
disease_progression 
H-positive risk:  666 640 75 1105 439 101 1150 409 148 55 149 63 
H-negative risk:  640 666 1150 1105 409 439 101 75 149 148 63 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
191 
disease_progression 
H-positive risk:  660 636 76 1106 445 104 1145 415 145 54 150 64 
H-negative risk:  636 660 1145 1106 415 445 104 76 150 145 64 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
60 new agents 
192 
disease_progression 
H-positive risk:  664 636 79 1107 444 104 1138 410 145 58 148 67 
H-negative risk:  636 664 1138 1107 410 444 104 79 148 145 67 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
66 new agents 
193 
disease_progression 
H-positive risk:  665 635 80 1112 436 103 1137 416 143 60 148 65 
H-negative risk:  635 665 1137 1112 416 436 103 80 148 143 65 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 87 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
194 
disease_progression 
H-positive risk:  662 630 79 1109 440 102 1134 425 140 64 152 63 
H-negative risk:  630 662 1134 1109 425 440 102 79 152 140 63 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
195 
disease_progression 
H-positive risk:  657 638 79 1111 430 102 1140 425 139 65 151 63 
H-negative risk:  638 657 1140 1111 425 430 102 79 151 139 63 65 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
196 
disease_progression 
H-positive risk:  655 633 79 1114 426 100 1141 431 142 64 151 64 
H-negative risk:  633 655 1141 1114 431 426 100 79 151 142 64 64 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
197 
disease_progression 
H-positive risk:  653 649 81 1106 418 101 1141 433 140 64 150 64 
H-negative risk:  649 653 1141 1106 433 418 101 81 150 140 64 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
198 
disease_progression 
H-positive risk:  657 656 83 1102 415 102 1141 439 137 63 145 60 
H-negative risk:  656 657 1141 1102 439 415 102 83 145 137 60 63 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
199 
disease_progression 
H-positive risk:  659 655 82 1098 414 105 1137 442 135 64 150 59 
H-negative risk:  655 659 1137 1098 442 414 105 82 150 135 59 64 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 97 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
200 
disease_progression 
H-positive risk:  660 658 81 1092 410 107 1135 448 135 61 152 61 
H-negative risk:  658 660 1135 1092 448 410 107 81 152 135 61 61 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 96 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
201 
disease_progression 
H-positive risk:  656 657 84 1089 419 104 1136 447 134 61 147 66 
H-negative risk:  657 656 1136 1089 447 419 104 84 147 134 66 61 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 98 32 

clinical_engagement 
diagnosis 
demography 
89 new agents 
202 
disease_progression 
H-positive risk:  652 650 88 1094 415 100 1130 459 136 64 145 67 
H-negative risk:  650 652 1130 1094 459 415 100 88 145 136 67 64 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 95 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
203 
disease_progression 
H-positive risk:  655 653 89 1095 419 97 1119 458 138 66 145 66 
H-negative risk:  653 655 1119 1095 458 419 97 89 145 138 66 66 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 95 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
204 
disease_progression 
H-positive risk:  656 653 91 1097 426 96 1122 443 139 65 146 66 
H-negative risk:  653 656 1122 1097 443 426 96 91 146 139 66 65 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 93 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
205 
disease_progression 
H-positive risk:  662 655 91 1089 426 94 1126 446 140 61 145 65 
H-negative risk:  655 662 1126 1089 446 426 94 91 145 140 65 61 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 94 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
206 
disease_progression 
H-positive risk:  666 653 94 1074 442 95 1113 451 145 59 145 63 
H-negative risk:  653 666 1113 1074 451 442 95 94 145 145 63 59 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 96 30 

clinical_engagement 
diagnosis 
demography 
91 new agents 
207 
disease_progression 
H-positive risk:  674 653 94 1080 438 95 1111 444 145 55 145 66 
H-negative risk:  653 674 1111 1080 444 438 95 94 145 145 66 55 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 98 30 

clinical_engagement 
diagnosis 
demography 
86 new agents 
208 
disease_progression 
H-positive risk:  665 650 95 1085 433 94 1126 440 147 58 145 62 
H-negative risk:  650 665 1126 1085 440 433 94 95 145 147 62 58 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 94 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
209 
disease_progression 
H-positive risk:  674 646 99 1084 424 93 1126 438 150 59 145 62 
H-negative risk:  646 674 1126 1084 438 424 93 99 145 150 62 59 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 95 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
210 
disease_progression 
H-positive risk:  666 649 97 1089 421 93 1140 440 148 57 142 58 
H-negative risk:  649 666 1140 1089 440 421 93 97 142 148 58 57 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 95 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
211 
disease_progression 
H-positive risk:  663 651 97 1090 427 94 1139 436 149 58 138 58 
H-negative risk:  651 663 1139 1090 436 427 94 97 138 149 58 58 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 95 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
212 
disease_progression 
H-positive risk:  657 653 100 1089 429 94 1157 425 147 57 139 53 
H-negative risk:  653 657 1157 1089 425 429 94 100 139 147 53 57 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 93 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
213 
disease_progression 
H-positive risk:  662 655 102 1077 432 94 1157 430 145 57 135 54 
H-negative risk:  655 662 1157 1077 430 432 94 102 135 145 54 57 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 91 35 

clinical_engagement 
diagnosis 
demography 
69 new agents 
214 
disease_progression 
H-positive risk:  659 652 100 1077 434 96 1153 430 148 58 134 59 
H-negative risk:  652 659 1153 1077 430 434 96 100 134 148 59 58 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 94 34 

clinical_engagement 
diagnosis 
demography 
61 new agents 
215 
disease_progression 
H-positive risk:  658 657 101 1083 437 96 1151 419 147 58 131 62 
H-negative risk:  657 658 1151 1083 419 437 96 101 131 147 62 58 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 94 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
216 
disease_progression 
H-positive risk:  656 659 99 1080 441 99 1154 414 144 59 136 59 
H-negative risk:  659 656 1154 1080 414 441 99 99 136 144 59 59 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 94 35 

clinical_engagement 
diagnosis 
demography 
77 new agents 
217 
disease_progression 
H-positive risk:  660 658 100 1075 450 101 1139 418 144 56 138 61 
H-negative risk:  658 660 1139 1075 418 450 101 100 138 144 61 56 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 96 35 

clinical_engagement 
diagnosis 
demography 
102 new agents 
218 
disease_progression 
H-positive risk:  653 665 103 1080 438 105 1146 411 145 56 138 60 
H-negative risk:  665 653 1146 1080 411 438 105 103 138 145 60 56 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 96 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
219 
disease_progression 
H-positive risk:  654 663 103 1081 440 103 1142 411 146 57 139 61 
H-negative risk:  663 654 1142 1081 411 440 103 103 139 146 61 57 
New BC onsets:  136
BC status:  4864 136 
BC subtype:  4864 102 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
220 
disease_progression 
H-positive risk:  661 670 104 1067 443 103 1142 406 146 58 138 62 
H-negative risk:  670 661 1142 1067 406 443 103 104 138 146 62 58 
New BC onsets:  137
BC status:  4863 137 
BC subtype:  4863 106 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
221 
disease_progression 
H-positive risk:  658 671 106 1065 442 104 1150 397 148 58 138 63 
H-negative risk:  671 658 1150 1065 397 442 104 106 138 148 63 58 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 104 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
222 
disease_progression 
H-positive risk:  663 674 105 1073 440 107 1139 395 147 58 136 63 
H-negative risk:  674 663 1139 1073 395 440 107 105 136 147 63 58 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 102 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
223 
disease_progression 
H-positive risk:  666 675 103 1071 444 107 1138 397 145 56 138 60 
H-negative risk:  675 666 1138 1071 397 444 107 103 138 145 60 56 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 102 30 

clinical_engagement 
diagnosis 
demography 
57 new agents 
224 
disease_progression 
H-positive risk:  663 672 103 1069 450 106 1139 400 146 55 136 61 
H-negative risk:  672 663 1139 1069 400 450 106 103 136 146 61 55 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 104 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
225 
disease_progression 
H-positive risk:  664 673 104 1070 452 108 1128 403 146 54 135 63 
H-negative risk:  673 664 1128 1070 403 452 108 104 135 146 63 54 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 101 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
226 
disease_progression 
H-positive risk:  657 671 104 1073 455 108 1128 410 142 55 135 62 
H-negative risk:  671 657 1128 1073 410 455 108 104 135 142 62 55 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 99 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
227 
disease_progression 
H-positive risk:  650 671 106 1085 456 107 1123 414 142 54 132 60 
H-negative risk:  671 650 1123 1085 414 456 107 106 132 142 60 54 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 95 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
228 
disease_progression 
H-positive risk:  645 678 106 1092 449 105 1115 418 142 57 133 60 
H-negative risk:  678 645 1115 1092 418 449 105 106 133 142 60 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
229 
disease_progression 
H-positive risk:  636 677 107 1074 463 105 1105 442 142 58 132 59 
H-negative risk:  677 636 1105 1074 442 463 105 107 132 142 59 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
230 
disease_progression 
H-positive risk:  636 676 105 1074 464 104 1113 437 141 59 136 55 
H-negative risk:  676 636 1113 1074 437 464 104 105 136 141 55 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
231 
disease_progression 
H-positive risk:  633 677 107 1059 469 106 1106 449 140 58 138 58 
H-negative risk:  677 633 1106 1059 449 469 106 107 138 140 58 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
232 
disease_progression 
H-positive risk:  633 681 108 1061 464 107 1094 460 139 57 138 58 
H-negative risk:  681 633 1094 1061 460 464 107 108 138 139 58 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 94 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
233 
disease_progression 
H-positive risk:  636 678 109 1066 464 108 1095 450 138 58 140 58 
H-negative risk:  678 636 1095 1066 450 464 108 109 140 138 58 58 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 95 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
234 
disease_progression 
H-positive risk:  634 679 111 1065 463 108 1089 451 141 58 143 58 
H-negative risk:  679 634 1089 1065 451 463 108 111 143 141 58 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
235 
disease_progression 
H-positive risk:  631 682 110 1074 456 109 1091 446 143 57 143 58 
H-negative risk:  682 631 1091 1074 446 456 109 110 143 143 58 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
236 
disease_progression 
H-positive risk:  625 688 111 1079 449 107 1094 445 147 55 141 59 
H-negative risk:  688 625 1094 1079 445 449 107 111 141 147 59 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
95 new agents 
237 
disease_progression 
H-positive risk:  624 693 110 1078 447 109 1100 437 147 56 141 58 
H-negative risk:  693 624 1100 1078 437 447 109 110 141 147 58 56 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
238 
disease_progression 
H-positive risk:  629 689 111 1076 441 110 1106 438 146 55 142 57 
H-negative risk:  689 629 1106 1076 438 441 110 111 142 146 57 55 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
239 
disease_progression 
H-positive risk:  628 681 111 1081 440 108 1098 444 150 57 144 58 
H-negative risk:  681 628 1098 1081 444 440 108 111 144 150 58 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
240 
disease_progression 
H-positive risk:  626 674 110 1087 438 106 1100 442 150 59 147 61 
H-negative risk:  674 626 1100 1087 442 438 106 110 147 150 61 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
241 
disease_progression 
H-positive risk:  624 677 108 1086 445 105 1094 440 148 63 147 63 
H-negative risk:  677 624 1094 1086 440 445 105 108 147 148 63 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
99 new agents 
242 
disease_progression 
H-positive risk:  618 678 107 1095 445 107 1090 441 148 65 146 60 
H-negative risk:  678 618 1090 1095 441 445 107 107 146 148 60 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
243 
disease_progression 
H-positive risk:  619 680 108 1085 451 108 1091 440 147 65 146 60 
H-negative risk:  680 619 1091 1085 440 451 108 108 146 147 60 65 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 97 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
244 
disease_progression 
H-positive risk:  620 682 105 1086 451 108 1087 442 149 66 148 56 
H-negative risk:  682 620 1087 1086 442 451 108 105 148 149 56 66 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 99 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
245 
disease_progression 
H-positive risk:  620 684 105 1091 446 111 1092 437 150 64 146 54 
H-negative risk:  684 620 1092 1091 437 446 111 105 146 150 54 64 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
246 
disease_progression 
H-positive risk:  620 684 104 1088 452 110 1085 444 153 63 144 53 
H-negative risk:  684 620 1085 1088 444 452 110 104 144 153 53 63 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
247 
disease_progression 
H-positive risk:  625 690 106 1093 443 110 1080 443 153 65 142 50 
H-negative risk:  690 625 1080 1093 443 443 110 106 142 153 50 65 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 101 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
248 
disease_progression 
H-positive risk:  625 691 105 1091 449 108 1084 443 150 64 143 47 
H-negative risk:  691 625 1084 1091 443 449 108 105 143 150 47 64 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
97 new agents 
249 
disease_progression 
H-positive risk:  629 697 103 1089 445 110 1077 441 154 64 140 51 
H-negative risk:  697 629 1077 1089 441 445 110 103 140 154 51 64 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
250 
disease_progression 
H-positive risk:  633 695 103 1093 448 107 1076 435 156 62 142 50 
H-negative risk:  695 633 1076 1093 435 448 107 103 142 156 50 62 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 104 19 

clinical_engagement 
diagnosis 
demography 
90 new agents 
251 
disease_progression 
H-positive risk:  635 691 102 1096 446 104 1081 432 156 61 145 51 
H-negative risk:  691 635 1081 1096 432 446 104 102 145 156 51 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
252 
disease_progression 
H-positive risk:  641 694 105 1085 455 102 1076 430 157 58 145 52 
H-negative risk:  694 641 1076 1085 430 455 102 105 145 157 52 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
253 
disease_progression 
H-positive risk:  645 691 104 1091 450 100 1074 428 162 58 150 47 
H-negative risk:  691 645 1074 1091 428 450 100 104 150 162 47 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
254 
disease_progression 
H-positive risk:  646 700 105 1092 446 101 1073 423 159 55 152 48 
H-negative risk:  700 646 1073 1092 423 446 101 105 152 159 48 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
255 
disease_progression 
H-positive risk:  647 699 102 1086 442 101 1069 435 159 56 155 49 
H-negative risk:  699 647 1069 1086 435 442 101 102 155 159 49 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 94 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
256 
disease_progression 
H-positive risk:  644 700 99 1081 450 101 1071 432 160 55 156 51 
H-negative risk:  700 644 1071 1081 432 450 101 99 156 160 51 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
257 
disease_progression 
H-positive risk:  643 696 96 1097 451 100 1068 428 157 57 158 49 
H-negative risk:  696 643 1068 1097 428 451 100 96 158 157 49 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 95 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
258 
disease_progression 
H-positive risk:  650 686 96 1100 448 101 1076 418 153 63 155 54 
H-negative risk:  686 650 1076 1100 418 448 101 96 155 153 54 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 94 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
259 
disease_progression 
H-positive risk:  649 678 91 1106 441 102 1086 418 153 63 158 55 
H-negative risk:  678 649 1086 1106 418 441 102 91 158 153 55 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 93 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
260 
disease_progression 
H-positive risk:  656 681 92 1108 434 105 1085 414 151 61 159 54 
H-negative risk:  681 656 1085 1108 414 434 105 92 159 151 54 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
261 
disease_progression 
H-positive risk:  658 681 93 1108 432 106 1081 416 148 64 159 54 
H-negative risk:  681 658 1081 1108 416 432 106 93 159 148 54 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
262 
disease_progression 
H-positive risk:  660 681 96 1109 438 107 1080 405 147 65 156 56 
H-negative risk:  681 660 1080 1109 405 438 107 96 156 147 56 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
103 new agents 
263 
disease_progression 
H-positive risk:  657 690 96 1111 430 108 1094 401 142 65 152 54 
H-negative risk:  690 657 1094 1111 401 430 108 96 152 142 54 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
85 new agents 
264 
disease_progression 
H-positive risk:  659 697 92 1119 424 110 1090 393 140 66 156 54 
H-negative risk:  697 659 1090 1119 393 424 110 92 156 140 54 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
265 
disease_progression 
H-positive risk:  661 697 92 1117 423 110 1089 389 143 66 155 58 
H-negative risk:  697 661 1089 1117 389 423 110 92 155 143 58 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
266 
disease_progression 
H-positive risk:  667 691 94 1120 422 109 1083 390 142 65 157 60 
H-negative risk:  691 667 1083 1120 390 422 109 94 157 142 60 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
267 
disease_progression 
H-positive risk:  669 691 93 1124 421 109 1082 390 141 66 155 59 
H-negative risk:  691 669 1082 1124 390 421 109 93 155 141 59 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
268 
disease_progression 
H-positive risk:  663 685 92 1134 424 104 1092 383 144 66 152 61 
H-negative risk:  685 663 1092 1134 383 424 104 92 152 144 61 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
269 
disease_progression 
H-positive risk:  660 684 96 1124 424 104 1097 384 144 68 154 61 
H-negative risk:  684 660 1097 1124 384 424 104 96 154 144 61 68 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
87 new agents 
270 
disease_progression 
H-positive risk:  675 684 95 1115 424 101 1094 384 147 67 153 61 
H-negative risk:  684 675 1094 1115 384 424 101 95 153 147 61 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 90 14 

clinical_engagement 
diagnosis 
demography 
72 new agents 
271 
disease_progression 
H-positive risk:  679 690 95 1114 418 100 1087 388 149 67 153 60 
H-negative risk:  690 679 1087 1114 388 418 100 95 153 149 60 67 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 92 13 

clinical_engagement 
diagnosis 
demography 
90 new agents 
272 
disease_progression 
H-positive risk:  682 693 94 1113 417 104 1074 391 149 70 153 60 
H-negative risk:  693 682 1074 1113 391 417 104 94 153 149 60 70 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 89 14 

clinical_engagement 
diagnosis 
demography 
83 new agents 
273 
disease_progression 
H-positive risk:  677 696 95 1112 413 100 1081 394 149 72 152 59 
H-negative risk:  696 677 1081 1112 394 413 100 95 152 149 59 72 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 89 14 

clinical_engagement 
diagnosis 
demography 
86 new agents 
274 
disease_progression 
H-positive risk:  680 700 96 1113 415 99 1083 388 151 69 150 56 
H-negative risk:  700 680 1083 1113 388 415 99 96 150 151 56 69 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
87 new agents 
275 
disease_progression 
H-positive risk:  677 702 95 1105 411 100 1086 397 151 69 147 60 
H-negative risk:  702 677 1086 1105 397 411 100 95 147 151 60 69 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 89 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
276 
disease_progression 
H-positive risk:  679 698 96 1098 420 99 1082 404 154 64 145 61 
H-negative risk:  698 679 1082 1098 404 420 99 96 145 154 61 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
277 
disease_progression 
H-positive risk:  679 702 97 1100 414 96 1085 400 154 67 142 64 
H-negative risk:  702 679 1085 1100 400 414 96 97 142 154 64 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
278 
disease_progression 
H-positive risk:  676 698 98 1096 416 96 1090 403 154 66 144 63 
H-negative risk:  698 676 1090 1096 403 416 96 98 144 154 63 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
84 new agents 
279 
disease_progression 
H-positive risk:  687 693 98 1096 415 96 1087 404 153 64 145 62 
H-negative risk:  693 687 1087 1096 404 415 96 98 145 153 62 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
280 
disease_progression 
H-positive risk:  685 690 99 1099 423 96 1088 398 153 64 146 59 
H-negative risk:  690 685 1088 1099 398 423 96 99 146 153 59 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
281 
disease_progression 
H-positive risk:  685 693 98 1091 422 97 1091 402 153 64 145 59 
H-negative risk:  693 685 1091 1091 402 422 97 98 145 153 59 64 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
282 
disease_progression 
H-positive risk:  677 687 98 1083 435 99 1092 404 154 63 146 62 
H-negative risk:  687 677 1092 1083 404 435 99 98 146 154 62 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
283 
disease_progression 
H-positive risk:  682 678 97 1096 434 96 1091 402 154 62 147 61 
H-negative risk:  678 682 1091 1096 402 434 96 97 147 154 61 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
284 
disease_progression 
H-positive risk:  683 674 98 1103 428 94 1094 397 159 62 146 62 
H-negative risk:  674 683 1094 1103 397 428 94 98 146 159 62 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
285 
disease_progression 
H-positive risk:  686 676 96 1108 417 93 1093 397 161 62 147 64 
H-negative risk:  676 686 1093 1108 397 417 93 96 147 161 64 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
286 
disease_progression 
H-positive risk:  684 677 97 1109 423 96 1093 393 160 61 141 66 
H-negative risk:  677 684 1093 1109 393 423 96 97 141 160 66 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
287 
disease_progression 
H-positive risk:  688 676 99 1102 426 99 1093 392 160 61 138 66 
H-negative risk:  676 688 1093 1102 392 426 99 99 138 160 66 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
288 
disease_progression 
H-positive risk:  682 681 98 1090 436 98 1097 392 161 59 139 67 
H-negative risk:  681 682 1097 1090 392 436 98 98 139 161 67 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
289 
disease_progression 
H-positive risk:  691 685 100 1085 432 100 1093 387 159 62 141 65 
H-negative risk:  685 691 1093 1085 387 432 100 100 141 159 65 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
93 new agents 
290 
disease_progression 
H-positive risk:  697 688 99 1080 428 100 1091 389 161 65 139 63 
H-negative risk:  688 697 1091 1080 389 428 100 99 139 161 63 65 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
291 
disease_progression 
H-positive risk:  693 690 101 1079 430 101 1082 400 160 65 137 62 
H-negative risk:  690 693 1082 1079 400 430 101 101 137 160 62 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
292 
disease_progression 
H-positive risk:  689 688 99 1086 425 101 1083 400 161 66 141 61 
H-negative risk:  688 689 1083 1086 400 425 101 99 141 161 61 66 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
293 
disease_progression 
H-positive risk:  694 685 96 1073 437 100 1091 390 164 67 144 59 
H-negative risk:  685 694 1091 1073 390 437 100 96 144 164 59 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
294 
disease_progression 
H-positive risk:  690 681 96 1067 438 99 1097 395 162 69 145 61 
H-negative risk:  681 690 1097 1067 395 438 99 96 145 162 61 69 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
295 
disease_progression 
H-positive risk:  688 684 94 1067 432 102 1099 401 158 69 147 59 
H-negative risk:  684 688 1099 1067 401 432 102 94 147 158 59 69 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
56 new agents 
296 
disease_progression 
H-positive risk:  690 681 94 1061 444 103 1095 398 159 68 149 58 
H-negative risk:  681 690 1095 1061 398 444 103 94 149 159 58 68 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
297 
disease_progression 
H-positive risk:  687 682 95 1061 450 105 1093 395 159 67 147 59 
H-negative risk:  682 687 1093 1061 395 450 105 95 147 159 59 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
298 
disease_progression 
H-positive risk:  683 674 94 1070 448 102 1102 391 162 63 153 58 
H-negative risk:  674 683 1102 1070 391 448 102 94 153 162 58 63 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
299 
disease_progression 
H-positive risk:  677 676 93 1072 457 100 1105 389 159 61 153 58 
H-negative risk:  676 677 1105 1072 389 457 100 93 153 159 58 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
300 
disease_progression 
H-positive risk:  676 678 94 1078 451 98 1096 391 164 62 154 58 
H-negative risk:  678 676 1096 1078 391 451 98 94 154 164 58 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
301 
disease_progression 
H-positive risk:  677 673 93 1070 452 100 1100 395 163 61 158 58 
H-negative risk:  673 677 1100 1070 395 452 100 93 158 163 58 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
302 
disease_progression 
H-positive risk:  675 662 89 1078 456 104 1103 387 166 61 160 59 
H-negative risk:  662 675 1103 1078 387 456 104 89 160 166 59 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 91 17 

clinical_engagement 
diagnosis 
demography 
81 new agents 
303 
disease_progression 
H-positive risk:  679 667 86 1066 459 105 1112 383 164 60 162 57 
H-negative risk:  667 679 1112 1066 383 459 105 86 162 164 57 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
304 
disease_progression 
H-positive risk:  682 675 85 1071 459 103 1101 387 165 57 159 56 
H-negative risk:  675 682 1101 1071 387 459 103 85 159 165 56 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
305 
disease_progression 
H-positive risk:  687 666 86 1082 462 101 1085 390 168 58 157 58 
H-negative risk:  666 687 1085 1082 390 462 101 86 157 168 58 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
306 
disease_progression 
H-positive risk:  691 663 85 1074 463 103 1087 390 168 57 159 60 
H-negative risk:  663 691 1087 1074 390 463 103 85 159 168 60 57 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
307 
disease_progression 
H-positive risk:  687 657 87 1074 455 108 1090 398 169 55 157 63 
H-negative risk:  657 687 1090 1074 398 455 108 87 157 169 63 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
308 
disease_progression 
H-positive risk:  690 658 89 1065 457 108 1088 398 173 54 157 63 
H-negative risk:  658 690 1088 1065 398 457 108 89 157 173 63 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
309 
disease_progression 
H-positive risk:  689 656 88 1075 457 109 1087 396 172 51 158 62 
H-negative risk:  656 689 1087 1075 396 457 109 88 158 172 62 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
310 
disease_progression 
H-positive risk:  687 659 88 1067 461 108 1082 403 174 52 161 58 
H-negative risk:  659 687 1082 1067 403 461 108 88 161 174 58 52 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
311 
disease_progression 
H-positive risk:  679 662 90 1081 450 108 1075 406 176 54 161 58 
H-negative risk:  662 679 1075 1081 406 450 108 90 161 176 58 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
312 
disease_progression 
H-positive risk:  694 664 91 1088 435 108 1069 409 172 53 160 57 
H-negative risk:  664 694 1069 1088 409 435 108 91 160 172 57 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
313 
disease_progression 
H-positive risk:  692 663 90 1096 430 107 1075 411 171 54 156 55 
H-negative risk:  663 692 1075 1096 411 430 107 90 156 171 55 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
314 
disease_progression 
H-positive risk:  682 665 88 1096 433 107 1077 412 172 55 157 56 
H-negative risk:  665 682 1077 1096 412 433 107 88 157 172 56 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
95 new agents 
315 
disease_progression 
H-positive risk:  692 663 88 1092 433 105 1083 408 171 55 157 53 
H-negative risk:  663 692 1083 1092 408 433 105 88 157 171 53 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
91 new agents 
316 
disease_progression 
H-positive risk:  692 669 91 1081 434 103 1077 413 170 56 160 54 
H-negative risk:  669 692 1077 1081 413 434 103 91 160 170 54 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
317 
disease_progression 
H-positive risk:  687 674 91 1081 430 104 1081 410 168 61 157 56 
H-negative risk:  674 687 1081 1081 410 430 104 91 157 168 56 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
318 
disease_progression 
H-positive risk:  690 664 91 1082 426 105 1087 416 167 57 159 56 
H-negative risk:  664 690 1087 1082 416 426 105 91 159 167 56 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
319 
disease_progression 
H-positive risk:  689 665 91 1085 422 106 1086 416 165 60 159 56 
H-negative risk:  665 689 1086 1085 416 422 106 91 159 165 56 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
320 
disease_progression 
H-positive risk:  684 663 92 1098 421 105 1087 415 163 61 154 57 
H-negative risk:  663 684 1087 1098 415 421 105 92 154 163 57 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
321 
disease_progression 
H-positive risk:  685 668 91 1096 412 105 1091 414 163 59 158 58 
H-negative risk:  668 685 1091 1096 414 412 105 91 158 163 58 59 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
322 
disease_progression 
H-positive risk:  687 672 93 1093 411 106 1092 409 165 58 156 58 
H-negative risk:  672 687 1092 1093 409 411 106 93 156 165 58 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
323 
disease_progression 
H-positive risk:  684 668 93 1090 420 106 1085 414 166 57 158 59 
H-negative risk:  668 684 1085 1090 414 420 106 93 158 166 59 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
324 
disease_progression 
H-positive risk:  669 681 96 1075 428 109 1094 416 163 56 155 58 
H-negative risk:  681 669 1094 1075 416 428 109 96 155 163 58 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
325 
disease_progression 
H-positive risk:  668 682 97 1085 425 110 1090 417 163 53 152 58 
H-negative risk:  682 668 1090 1085 417 425 110 97 152 163 58 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
326 
disease_progression 
H-positive risk:  666 683 101 1078 429 111 1092 422 160 50 149 59 
H-negative risk:  683 666 1092 1078 422 429 111 101 149 160 59 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
327 
disease_progression 
H-positive risk:  665 664 101 1096 432 112 1098 413 155 48 155 61 
H-negative risk:  664 665 1098 1096 413 432 112 101 155 155 61 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
328 
disease_progression 
H-positive risk:  669 670 101 1091 427 112 1090 423 157 45 152 63 
H-negative risk:  670 669 1090 1091 423 427 112 101 152 157 63 45 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
329 
disease_progression 
H-positive risk:  680 668 101 1093 424 110 1086 420 161 43 153 61 
H-negative risk:  668 680 1086 1093 420 424 110 101 153 161 61 43 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 84 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
330 
disease_progression 
H-positive risk:  669 673 102 1097 416 109 1094 423 164 43 147 63 
H-negative risk:  673 669 1094 1097 423 416 109 102 147 164 63 43 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 85 33 

clinical_engagement 
diagnosis 
demography 
73 new agents 
331 
disease_progression 
H-positive risk:  680 677 97 1093 411 112 1091 417 163 47 149 63 
H-negative risk:  677 680 1091 1093 417 411 112 97 149 163 63 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 85 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
332 
disease_progression 
H-positive risk:  679 689 98 1095 408 113 1079 420 162 44 151 62 
H-negative risk:  689 679 1079 1095 420 408 113 98 151 162 62 44 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 86 35 

clinical_engagement 
diagnosis 
demography 
78 new agents 
333 
disease_progression 
H-positive risk:  685 680 100 1108 403 112 1080 412 164 45 152 59 
H-negative risk:  680 685 1080 1108 412 403 112 100 152 164 59 45 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 88 35 

clinical_engagement 
diagnosis 
demography 
71 new agents 
334 
disease_progression 
H-positive risk:  690 683 99 1097 406 112 1084 409 163 44 153 60 
H-negative risk:  683 690 1084 1097 409 406 112 99 153 163 60 44 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 85 36 

clinical_engagement 
diagnosis 
demography 
90 new agents 
335 
disease_progression 
H-positive risk:  691 689 102 1094 407 114 1071 409 164 46 153 60 
H-negative risk:  689 691 1071 1094 409 407 114 102 153 164 60 46 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 86 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
336 
disease_progression 
H-positive risk:  693 681 102 1098 405 115 1069 420 160 46 151 60 
H-negative risk:  681 693 1069 1098 420 405 115 102 151 160 60 46 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 89 34 

clinical_engagement 
diagnosis 
demography 
70 new agents 
337 
disease_progression 
H-positive risk:  688 685 98 1095 405 116 1069 426 160 47 153 58 
H-negative risk:  685 688 1069 1095 426 405 116 98 153 160 58 47 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 88 35 

clinical_engagement 
diagnosis 
demography 
77 new agents 
338 
disease_progression 
H-positive risk:  683 682 99 1100 402 116 1066 429 163 48 154 58 
H-negative risk:  682 683 1066 1100 429 402 116 99 154 163 58 48 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 87 36 

clinical_engagement 
diagnosis 
demography 
69 new agents 
339 
disease_progression 
H-positive risk:  681 678 99 1108 406 114 1061 432 164 46 154 57 
H-negative risk:  678 681 1061 1108 432 406 114 99 154 164 57 46 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 87 34 

clinical_engagement 
diagnosis 
demography 
84 new agents 
340 
disease_progression 
H-positive risk:  689 667 99 1114 401 114 1062 426 168 46 153 61 
H-negative risk:  667 689 1062 1114 426 401 114 99 153 168 61 46 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 89 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
341 
disease_progression 
H-positive risk:  687 670 98 1115 411 114 1060 422 167 46 150 60 
H-negative risk:  670 687 1060 1115 422 411 114 98 150 167 60 46 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 87 33 

clinical_engagement 
diagnosis 
demography 
82 new agents 
342 
disease_progression 
H-positive risk:  681 674 98 1117 409 115 1060 423 166 49 149 59 
H-negative risk:  674 681 1060 1117 423 409 115 98 149 166 59 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
343 
disease_progression 
H-positive risk:  678 684 102 1111 407 115 1067 420 164 49 145 58 
H-negative risk:  684 678 1067 1111 420 407 115 102 145 164 58 49 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 83 31 

clinical_engagement 
diagnosis 
demography 
65 new agents 
344 
disease_progression 
H-positive risk:  675 683 102 1110 407 115 1068 423 162 48 148 59 
H-negative risk:  683 675 1068 1110 423 407 115 102 148 162 59 48 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
54 new agents 
345 
disease_progression 
H-positive risk:  661 685 101 1107 414 108 1075 424 167 50 150 58 
H-negative risk:  685 661 1075 1107 424 414 108 101 150 167 58 50 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
83 new agents 
346 
disease_progression 
H-positive risk:  656 688 102 1106 416 111 1071 425 168 50 150 57 
H-negative risk:  688 656 1071 1106 425 416 111 102 150 168 57 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
347 
disease_progression 
H-positive risk:  659 684 104 1111 417 115 1068 431 162 47 147 55 
H-negative risk:  684 659 1068 1111 431 417 115 104 147 162 55 47 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
348 
disease_progression 
H-positive risk:  666 684 103 1098 421 114 1067 434 160 48 147 58 
H-negative risk:  684 666 1067 1098 434 421 114 103 147 160 58 48 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
349 
disease_progression 
H-positive risk:  667 690 102 1097 422 113 1060 433 159 50 146 61 
H-negative risk:  690 667 1060 1097 433 422 113 102 146 159 61 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
65 new agents 
350 
disease_progression 
H-positive risk:  666 677 102 1103 426 114 1064 429 159 51 147 62 
H-negative risk:  677 666 1064 1103 429 426 114 102 147 159 62 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
351 
disease_progression 
H-positive risk:  662 679 103 1095 425 113 1069 434 159 51 146 64 
H-negative risk:  679 662 1069 1095 434 425 113 103 146 159 64 51 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
352 
disease_progression 
H-positive risk:  665 677 101 1096 423 112 1071 437 163 48 146 61 
H-negative risk:  677 665 1071 1096 437 423 112 101 146 163 61 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 84 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
353 
disease_progression 
H-positive risk:  663 684 101 1083 426 114 1068 437 165 48 151 60 
H-negative risk:  684 663 1068 1083 437 426 114 101 151 165 60 48 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
354 
disease_progression 
H-positive risk:  664 683 101 1076 426 114 1071 441 165 48 149 62 
H-negative risk:  683 664 1071 1076 441 426 114 101 149 165 62 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
355 
disease_progression 
H-positive risk:  669 678 103 1075 424 115 1077 437 165 46 147 64 
H-negative risk:  678 669 1077 1075 437 424 115 103 147 165 64 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
356 
disease_progression 
H-positive risk:  668 677 103 1085 425 113 1074 437 166 46 143 63 
H-negative risk:  677 668 1074 1085 437 425 113 103 143 166 63 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
357 
disease_progression 
H-positive risk:  673 678 104 1093 423 113 1070 433 164 47 137 65 
H-negative risk:  678 673 1070 1093 433 423 113 104 137 164 65 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
358 
disease_progression 
H-positive risk:  674 677 107 1089 419 111 1069 430 171 49 138 66 
H-negative risk:  677 674 1069 1089 430 419 111 107 138 171 66 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
359 
disease_progression 
H-positive risk:  676 679 103 1091 415 109 1066 430 174 51 140 66 
H-negative risk:  679 676 1066 1091 430 415 109 103 140 174 66 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
360 
disease_progression 
H-positive risk:  676 675 105 1092 410 109 1073 424 174 53 140 69 
H-negative risk:  675 676 1073 1092 424 410 109 105 140 174 69 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
Time difference of 19.74357 mins
This is task 12
